Newsletter

May 2018 Scorecard

The May 2018 scorecard for the signals generated from Rocket Tickers can be downloaded here. For more information regarding how you can trade these signals, see the article Trading Clinical Trials Try Rocket Tickers 30 days for free and cancel anytime! Subscribe here and check out the Training Webinar

0Comments

Published Study Supports Global Medical’s Expandable Lateral Technology

On May 15, Global Medical, Inc. (GMED) reported the results of a medical study that supported the benefits of the company’s Globus expandable lateral spacers. The study “Clinical and radiographic analysis of expandable versus static lateral lumbar interbody fusion devices with two-year follow-up” was published in the Journal of Spine Surgery. Dr. Joseph O’Brien, MD, […]

0Comments

Avinger Receives FDA Clearance for Patheris Lumivascular Artherectomy System

Avinger, Inc. reported on May 23 that the company has received 510(k) clearance from the FDA for its next-generation Pantheris Lumivascular atherectomy system. Lumivascular is the only technology that combines both real-time intravascular imaging with catheters to treat peripheral artery disease (PAD). This is the first image-guided atherectomy device for the treatment of PAD. Rocket […]

0Comments

Lannett Receives FDA Approval for Dronabinol Capsules

Lannett Company, Inc. (LCI) announced on May 21 that they have received FDA approval for Dronabinol Capsules. The drug is the therapeutic equivalent to Marinol Capsules, and only a handful of suppliers manufacture generic versions of the drug for the US market. Dronabinol Capsules can be used to treat patients with loss of appetite due […]

0Comments

RXi Reports Positive Phase 2 Clinical Trial Results for Treatment of Common Warts

On May 18, RXi Pharmaceuticals Corporation (RXII) reported positive results from its phase 2 clinical trial of the drug Samcyprone for the treatment of common warts. After weekly application for 10 weeks, participants had a 97.7% positive immunotherapy response rate. 70% of participants experienced a reduction of at least 50% wart size. There is currently […]

0Comments

Karypharm Reports Positive Results From Phase 2b Clinical Trial of Selinexor

On April 30, Karyopharm Therapeutics, Inc. (KPTI) announced positive results from its phase 2b STORM study examining the effect of Selinexor in patients with penta-refractory multiple myeloma. The clinical trial showed that patients had a 25.4% overall response rate to the treatment. Based on the results, Karyopharm plans to submit a New Drug Application to […]

0Comments

April 2018 Scorecard

The April 2018 scorecard for the signals generated from Rocket Tickers can be downloaded here. For more information regarding how you can trade these signals, see the article Trading Clinical Trials Try Rocket Tickers 30 days for free and cancel anytime! Subscribe here and check out the Training Webinar Remember to enter the promo code: […]

0Comments

Sientra Receives FDA Approval on Premarket Approval Supplement

Sientra, Inc. (SIEN) announced on April 18 that it had received FDA approval on its premarket approval (PMA) supplement. The approval allows Sientra to commercialize its OPUS-branded breast implant products manufactured at Vesta’s Wisconsin manufacturing facility. Sientra had been working closely with Vestra over the past two years on manufacturing the OPUS-branded breast implant, which […]

0Comments

Novocure Announces Positive Phase 2 Clinical Trial Results for Mesothelioma Patients

On April 17, Novocure (NVCR) announced positive results from its Phase 2 clinical trial for the treatment of mesothelioma. Patients who received Tumor Treatment Fields in addition to standard chemotherapy treatment experienced improvements in overall survival and progression. Novocure is a global oncology company developing its proprietary technology called Tumor Treating Fields, which use electric […]

0Comments

March 2018 Scorecard

The March 2018 scorecard for the signals generated from Rocket Tickers can be downloaded here. For more information regarding how you can trade these signals, see the article Trading Clinical Trials Try Rocket Tickers 30 days for free and cancel anytime! Subscribe here and check out the Training Webinar Remember to enter the promo code: […]

0Comments